Anwesha CHOWDHURY, Niloy SEN, Sujan BANİK

Prescribing pattern of antidiabetic drugs in type 2 diabetic patients of Noakhali city in Bangladesh

The aim of the study was to describe the recent trends in the prescription pattern of antidiabetic drugs and sociodemographic characteristics of type 2 diabetic patients in Noakhali city of Bangladesh. This hospital based prospective, cross-sectional study was carried out in three diabetic hospitals of Noakhali during the period of December, 2016 to February, 2017. A total of 200 outpatients were included in this study by following simple random procedure. Among 200 participants, 73.5% were treated with monotherapy and 26.5% were treated with polytherapy with the highest percentage (37.5%) of commonly prescribed group drugs of sulfonylureas, but lonely metformin (biguanide) was the most commonest (28%) drug among oral hypoglycemic agents. The most accounted fixed dose combination was sulfonylurea with biguanide, and biguanide with glucodiase inhibitors. The highly prescribed insulin preparations was insulin mixtures (11%) among the patients. Drugs were prescribed by traditional brand names (100%) of different local or foreign companies and 15% of prescription were contained at least one multivitamin supplement. It was focused from this study that oral hypoglycemic agents (OHA) yet dominate the prescribing pattern, but there was a shifting trend towards insulin preparation in the management of Type 2 diabetes mellitus.

PDF

___

Sutharson L, Hariharan RS, Vamsadhara C. Drug utilization study in diabetology outpatient setting of a tertiary hospital. Indian J Pharmacol 2003; 35: 237-40.
Hasamnis A, Patil S. Prescription pattern study in type 2 diabetes mellitus in an Indian referral hospital. Internet J Pharmacol 2008; 7: 1.
Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm 2014; 5: 79-83.
Sultana A, Banik S, Hossain MS, Billah MM, Afrin F. The prevalence of childhood overweight and obesity in the children of Noakhali city in Bangladesh. J Res Obes 2016; 2016: Article ID 216173.
Powers AC, Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Lango DL, Jameson JL, editors. Harrison`s Principles of Internal Medicine, 16th ed. McGraw-Hill, New York. 2005, pp 2152-2180.
Davis SN. Goodman and Gilman`s The Pharmacological Basis of Therapeutics, 11th ed. McGraw-Hill, United States of America. 2006, pp 1613-1645.
Mazid MA. Thoughts on Diabetic Awareness Day. The Financial Express. 2013. Available at ; http://print. thefinancialexpress-bd.com/old/index.php? (Last access ; 01 July 2017)
King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31.
Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications, estimates and projections to the year 2010. Diabetes Med 1997; 14: S1-S85.
Gerick JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 1998; 19: 491–503.
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26:S520.